Immutep

Developer of immunotherapies for the treatment of cancer and autoimmune diseases

placeSydney, New South Wales, Australia calendar_todayFounded 2001 groups35 employees language immutep.com

Innovation

32 patent families (10 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace steady. Cited 5,769 times.

YearFilings
20142
20165
20176
20188
20198
202010
20218
20229
202314
202414
202510
20262

Social engagement

Social engagement: 5.8K social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

6 investors on record.

Investor typeCountShare
Venture capital117%
Private equity117%
Bank & private debt117%
Other / undisclosed350%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

2 Mar 2026 · Assistant Accountant

21 Dec 2024 · Clinical Trials Associate CTA Support mwd - Admin Operations Assistance · Berlin

29 Nov 2024 · Clinical Trial Supply Manager mfd · Berlin

Based on job postings tracked across public sources.

Recent activity

19 May 2026
Milestone
regulatory
19 Mar 2026
Milestone
regulatory
5 Feb 2026
Milestone
regulatory
Coming soon